United Therapeutics (UTHR) Tops Q3 EPS by 23c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $487.61 --0%
EPS Growth %: -10.1%
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -10.1%
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $5.38, $0.23 better than the analyst estimate of $5.15. Revenue for the quarter came in at $609.4 million versus the consensus estimate of $587.9 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi turns more bullish on trucking stocks
- Herbalife board approves $250M share buyback over three years
- Merck (MRK) PT Raised to $170 at Guggenheim
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
